版本:
中国

BRIEF-Biogen Inc affirms strong efficacy of TECFIDERA in both clinical studies and real-world setting

Sept 14 Biogen Inc :

* New Data Affirm Strong Efficacy And well characterized safety profile of TECFIDERA in both clinical studies and real-world setting

* Risk profile of TECFIDERA remains favorable up to nine years Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐